Cargando…

Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma

Glioblastoma (GBM) is a strikingly heterogeneous and lethal brain tumor with very poor prognosis. LncRNAs play critical roles in the tumorigenesis of GBM through regulation of various cancer-related genes and signaling pathways. Here, we focused on the essential role of EMT and identified 78 upregul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, XinJie, Niu, Sha, Liu, JiaQiang, Fang, Jincheng, Wu, ZeYu, Ling, Shizhang, Di, GuangFu, Jiang, XiaoChun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654911/ https://www.ncbi.nlm.nih.gov/pubmed/34880375 http://dx.doi.org/10.1038/s41598-021-03213-y

Ejemplares similares

Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation
por: Gao, Yong, et al.
Publicado: (2021)

Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer
por: Li, Chengxin, et al.
Publicado: (2023)

Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma
por: Xia, Qi-Dong, et al.
Publicado: (2022)

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
por: Tao, Chuming, et al.
Publicado: (2021)

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma
por: Liang, Qingyu, et al.
Publicado: (2020)

A novel epithelial–mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer
por: Jin, Yichao, et al.
Publicado: (2023)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

HOTAIR lncRNA promotes epithelial–mesenchymal transition by redistributing LSD1 at regulatory chromatin regions
por: Jarroux, Julien, et al.
Publicado: (2021)

Identification and validation of an epithelial-mesenchymal transition-related lncRNA pairs prognostic model for gastric cancer
por: Song, Wanting, et al.
Publicado: (2023)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
por: Liang, Wei-Cheng, et al.
Publicado: (2015)

High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer
por: Zheng, Xiangxiang, et al.
Publicado: (2016)

LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells
por: Han, Ri, et al.
Publicado: (2019)

LncRNA-DANCR promotes growth and metastasis of colorectal cancer via activating epithelial-mesenchymal transition process
por: Wang, Beibei, et al.
Publicado: (2019)

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
por: Zhan, Yating, et al.
Publicado: (2023)

A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
por: Li, Xiaomeng, et al.
Publicado: (2021)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis
por: Li, Changshu, et al.
Publicado: (2023)

lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
por: Xu, Can, et al.
Publicado: (2022)

lncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-β-Induced Epithelial-Mesenchymal Transition
por: Wang, Peng, et al.
Publicado: (2020)

LncRNA HOTAIR/miR‐613/c‐met axis modulated epithelial‐mesenchymal transition of retinoblastoma cells
por: Yang, Ge, et al.
Publicado: (2018)

TGF-β/SMAD4-Regulated LncRNA-LINP1 Inhibits Epithelial-Mesenchymal Transition in Lung Cancer
por: Zhang, Chong, et al.
Publicado: (2018)

Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review
por: O’Brien, Stephen J., et al.
Publicado: (2020)

Curcumin attenuates lncRNA H19-induced epithelial-mesenchymal transition in tamoxifen-resistant breast cancer cells
por: Cai, Jiaqin, et al.
Publicado: (2021)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

LncRNA SNHG6 Induces Epithelial–Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944
por: Mao, Dandan, et al.
Publicado: (2022)

Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)

LncRNA AERRIE Is Required for Sulfatase 1 Expression, but Not for Endothelial-to-Mesenchymal Transition
por: Pham, Tan Phát, et al.
Publicado: (2021)

QiHuangYiShen Granules Modulate the Expression of LncRNA MALAT1 and Attenuate Epithelial-Mesenchymal Transition in Kidney of Diabetic Nephropathy Rats
por: Yuan, Li-sha, et al.
Publicado: (2023)

Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
por: Zhang, Zeyu, et al.
Publicado: (2022)

The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition
por: Battistelli, C, et al.
Publicado: (2017)

LncRNA TRERNA1 Function as an Enhancer of SNAI1 Promotes Gastric Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition
por: Wu, Huazhang, et al.
Publicado: (2017)

LncRNA NKILA Promotes Epithelial-Mesenchymal Transition of Liver Cancer Cells by Targeting miR-485-5p
por: Wang, Yuxu, et al.
Publicado: (2021)

LncRNA SRA mediates cell migration, invasion, and progression of ovarian cancer via NOTCH signaling and epithelial–mesenchymal transition
por: Kim, Lee Kyung, et al.
Publicado: (2021)

Downregulated lncRNA GAS5 and Upregulated miR-21 Lead to Epithelial–Mesenchymal Transition and Lung Metastasis of Osteosarcomas
por: Wang, Ying, et al.
Publicado: (2021)

Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma
por: Wang, Peipei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uthn0hea6k352r69k8ttcdiclq